Theyre being eyed as treatments for other conditions, too, such as Alzheimers and nonalcoholic fatty liver disease
Comparison With GLP-1 Receptor Agonists Studies have compared sitagliptin with GLP-1 receptor agonists in drug nave subjects with type 2 diabetes [exenatide, (110)] or as add on to other therapy for exenatide (111), semaglutide (112), albiglutide (113), and dulaglutide (114)
The slight acidity of the solution (pH approximately 3.04.0 at 0.1% concentration) protonates basic amino acid residues on poorly water-soluble peptides, increasing their net positive charge and improving electrostatic interaction with the surrounding aqueous solvent a mechanism that dramatically increases the solubility of many lyophilised peptide preparations that resist dissolution in neutral or alkaline aqueous conditions
3 Therefore, combining GLP-1 medication with a dedicated strength training program creates a synergistic effect, offering a more potent strategy for achieving comprehensive cardiometabolic health improvements and better long-term outcomes compared to relying on the medication alone
